Original Work

A core outcome set for efficacy of acute treatment of hereditary angioedema

591.

Petersen, R. S., Fijen, L. M., Apfelbacher, C., Magerl, M., Weller, K., Aberer, W., Adatia, A., Audhya, P., Bara, N. A., Betschel, S., Boccon-Gibod, I., Bouillet, L., Brodszki, N., Busse, P. J., Buttgereit, T., Bygum, A., Cancian, M., Craig, T., Csuka, D., Farkas, H., Fomina, D., Gil-Serrano, J., Gompels, M., Fogelbach, G. G., Guilarte, M., Hide, M., Kiani-Alikhan, S., Kinaciyan, T., Lenten, A., Lleonart, R., Longhurst, H., Lumry, W. R., Malbran, A., Malinauskiene, L., Matta Campos, J. J., Mendivil, J., Nieto-Martinez, S. A., Peter, J. G., Porebski, G., Reshef, A., Riedl, M., Valerieva, A., Waserman, S., Maurer, M., and Cohn, D. M.+: A core outcome set for efficacy of acute treatment of hereditary angioedema. J. Allergy Clin. Immunol. Pract. 2024: 12; 1614-1621. IF: 6.60

o.591

A core outcome set for efficacy of acute treatment of hereditary angioedema Read More »

Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice

589.

Cherrez-Ojeda, I.+, Bousquet, J., Giménez-Arnau, A., Godse, K., Krasowska, D., Bartosińska, J., Szczepanik-Kułak, P., Wawrzycki, B., Kolkhir, P., Allenova, A., Allenov A, Tkachenko S, Teovska Mitrevska N, Mijakoski D, Stoleski S, Kolacinska-Flont, M., Kuprys-Lipinska, I., Molinska, J., Kasperska-Zając, A., Zajac, M., Zamlynski, M., Mihaltan, F., Ulmeanu, R., Zalewska-Janowska, A., Tomaszewska, K., Al-Ahmad, M., Al-Nesf, M. A., Ibrahim, T., Aqel, S., Pesqué, D., Rodríguez-González, M., Wakida-Kuzunoki, G. H., Ramon, G. D., Ramon, G. N., Neisinger, S., Bonnekoh, H., Rukhadze, M., Khoshkhui, M., Fomina, D., Larenas-Linnemann, D., Košnik, M., Oztas Kara, R., Caballero López, C. G., Liu, Q., Ivancevich Juan, C., Ensina, L. F., Rosario, N., Kvedariene, V., Ben-Shoshan, M., Criado, R. F. J., Bauer, A., Cherrez, A., Chong-Neto, H., Rojo-Gutierrez, M. I., Rudenko, M., Larco Sousa, J. I., Lesiak, A., Matos, E., Muñoz, N., Tinoco, I., Moreno, J., Crespo Shijin, C., Hinostroza Logroño, R., Sagñay, J. C., Faytong-Haro, M., Robles-Velasco, K., Zuberbier, T., and Maurer, M.+: Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice. J. Allergy Clin. Immunol. Pract. 2024: 12; 1575-1583. IF: 6.60

o.589

Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice Read More »

Clinically uninvolved but not healthy – the skin of patients with atopic dermatitis is primed for itch and inflammation

588.

Moon, S., Stasikowska-Kanicka, O., Wagrowska-Danilewicz, M., Hawro, M., Metz, M., Maurer, M., and Hawro, T.+: Clinically uninvolved but not healthy – the skin of patients with atopic dermatitis is primed for itch and inflammation. J. Eur. Acad. Dermatol. Venereol. 2024: 38; 1089-1100. IF: 8.00

o.588

Clinically uninvolved but not healthy – the skin of patients with atopic dermatitis is primed for itch and inflammation Read More »

The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center

587.

Buttgereit, T., Vera, C., Aykanat, S., Weller, K., Gutsche, A., Maurer, M.+, and Magerl, M.: The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center. Front. Immunol. 2024: 15; 1405317. IF: 5.90

o.587

The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center Read More »

Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study

586.

Canonica, G. W., Kuna, P., Maurer, M., Mösges, R., Novak, Z., Papadopoulos, N., Rodriguez del Rio, P., and the Delphi study group: Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study. Drugs Context 2024: 13; 2024-2-3. IF: 2.80

o.586

Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study Read More »

Altered sweat composition due to changes in tight junction expression of sweat glands in cholinergic urticaria patients

585.

Daci, D., Altrichter, S.+, Grillet, F., Dib, S., Mouna, A., Kumar, S. S., Terhorst-Molawi, D., Maurer, M., Günzel, D., and Scheffel, J.+: Altered sweat composition due to changes in tight junction expression of sweat glands in cholinergic urticaria patients. Int. J. Mol. Sci. 2024: 25; 4658. IF: 4.90

o.585

Altered sweat composition due to changes in tight junction expression of sweat glands in cholinergic urticaria patients Read More »

Development and validation of a patient-reported outcome measure to assess disease control in chronic prurigo

583.

Metz, M.+, Zeidler, C., Hawro, T., Pereira, M., Maurer, M., Bonnekoh, H., Krause, K., Pritchard, T., Kwatra, S. G., Ständer, S., and Weller, K.+: Development and validation of a patient-reported outcome measure to assess disease control in chronic prurigo. JAMA Dermatol. 2024: 160; 187-193. IF: 11.00

o.583

Development and validation of a patient-reported outcome measure to assess disease control in chronic prurigo Read More »

Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study

582.

Demir, S.+, Eyice-Karabacak, D., Kocatürk, E., Ünal, D., Toprak, İ. D., Korkmaz, P., Aslan, A. F., İmren, I. G., Dikicier, B., Kahveci, N., Öztop, N., Kara, R. Ö., İşsever, H., Maurer, M., Weller, K., and Gelincik, A.: Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study. Clin. Transl. Allergy 2024: 14; e12342. IF: 4.00

o.582

Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study Read More »